Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1963 Feb;42(2):179–186. doi: 10.1172/JCI104704

INCREASED SUSCEPTIBILITY TO PYELONEPHRITIS DURING ACUTE HYPERTENSION BY ANGIOTENSIN II AND NOREPINEPHRINE*

Roger K Jones 1, Alvin P Shapiro 1
PMCID: PMC289266  PMID: 14029543

Full text

PDF
179

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BARER G. R. A comparison of the circulatory effects of angiotensin, vasopressin and adrenaline in the anaesthetized cat. J Physiol. 1961 Apr;156:49–66. doi: 10.1113/jphysiol.1961.sp006657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BOCK K. D., KRECKE H. J., KUHN H. M. Untersuchungen über die Wirkung von synthetischem Hypertensin II auf Blutdruck, Atmung und Extremitätendurchblutung des Menschen. Klin Wochenschr. 1958 Mar 15;36(6):254–261. doi: 10.1007/BF01479198. [DOI] [PubMed] [Google Scholar]
  3. BRAUDE A. I., SHAPIRO A. P., SIEMIENSKI J. Hematogenous pyelonephritis in rats. I. Its pathogenesis when produced by a simple new method. J Clin Invest. 1955 Oct;34(10):1489–1497. doi: 10.1172/JCI103200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. BRAUDE A. I., SHAPIRO A. P., SIEMIENSKI J. Hematogenous pyelonephritis in rats. III. Relationship of bacterial species to the pathogenesis of acute pyeionephritis. J Bacteriol. 1959 Mar;77(3):270–280. doi: 10.1128/jb.77.3.270-280.1959. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. DANIEL E. E., DAWKINS O., HUNT J. Selective depletion of rat aorta potassium by small pressor doses of norepinephrine. Am J Physiol. 1957 Jul;190(1):67–70. doi: 10.1152/ajplegacy.1957.190.1.67. [DOI] [PubMed] [Google Scholar]
  6. GENEST J. Angiotensin, aldosterone and human arterial hypertension. Can Med Assoc J. 1961 Feb 25;84:403–419. [PMC free article] [PubMed] [Google Scholar]
  7. GUZE L. B., KALMANSON G. M. Pyelonephritis. III. Observations on the association between chronic pyelonephritis and hypertension in the rat. Proc Soc Exp Biol Med. 1961 Nov;108:496–498. doi: 10.3181/00379727-108-26976. [DOI] [PubMed] [Google Scholar]
  8. HADDY F. J., MOLNAR J. I., BORDEN C. W., TEXTER E. C., Jr Comparison of direct effects of angiotensin and other vasoactive agents on small and large blood vessels in several vascular beds. Circulation. 1962 Jan;25:239–246. doi: 10.1161/01.cir.25.1.239. [DOI] [PubMed] [Google Scholar]
  9. HEPTINSTALL R. H. Experimental pyelonephritis. The effect of chronic infection on the blood pressure in the rat. Br J Exp Pathol. 1962 Jun;43:333–339. [PMC free article] [PubMed] [Google Scholar]
  10. LARAGH J. H., ANGERS M., KELLY W. G., LIEBERMAN S. Hypotensive agents and pressor substances. The effect of epinephrine, norepinephrine, angiotensin II, and others on the secretory rate of aldosterone in man. JAMA. 1960 Sep 17;174:234–240. doi: 10.1001/jama.1960.03030030014003. [DOI] [PubMed] [Google Scholar]
  11. MANDEL M. J., SAPIRSTEIN L. A. Effect of angiotensin infusion on regional blood flow and regional vascular resistance in the rat. Circ Res. 1962 May;10:807–816. doi: 10.1161/01.res.10.5.807. [DOI] [PubMed] [Google Scholar]
  12. OLIVER J., MACDOWELL M., WELT L. G., HOLLIDAY M. A., HOLLANDER W., Jr, WINTERS R. W., WILLIAMS T. F., SEGAR W. E. The renal lesions of electrolyte imbalance. I. The structural alterations in potassium-depleted rats. J Exp Med. 1957 Oct 1;106(4):563–574. doi: 10.1084/jem.106.4.563. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. PAGE I. H., BUMPUS F. M. Angiotensin. Physiol Rev. 1961 Apr;41:331–390. doi: 10.1152/physrev.1961.41.2.331. [DOI] [PubMed] [Google Scholar]
  14. SHAPIRO A. P., BRAUDE A. I., SIEMIENSKI J. Hematogenous pyelonephritis in rats. IV. Relationship of bacterial species to the pathogenesis and sequelae of chronic pyelonephritis. J Clin Invest. 1959 Jul;38(7):1228–1240. doi: 10.1172/JCI103898. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. SHAPIRO A. P., KOBERNICK J. L. Effects of unilateral nephrectomy and mixed infection on blood pressure of rats with experimental chronic pyelonephritis. Circ Res. 1959 Nov;7:936–942. doi: 10.1161/01.res.7.6.936. [DOI] [PubMed] [Google Scholar]
  16. SHAPIRO A. P. Susceptibility of rats with DCA hypertension to experimental pyelonephritis and aggravation of DCA hypertension by renal infection. J Lab Clin Med. 1960 May;55:715–725. [PubMed] [Google Scholar]
  17. SPITZNAGEL J. K., SCHROEDER H. A. Experimental pyelonephritis and hypertension in rats. Proc Soc Exp Biol Med. 1951 Aug;77(4):762–764. doi: 10.3181/00379727-77-18919. [DOI] [PubMed] [Google Scholar]
  18. TOBIAN L. Interrelationship of electrolytes, juxtaglomerular cells and hypertension. Physiol Rev. 1960 Apr;40:280–312. doi: 10.1152/physrev.1960.40.2.280. [DOI] [PubMed] [Google Scholar]
  19. WOODS J. W. Susceptibility of rats with hormonal hypertension to experimental pyelonephritis. J Clin Invest. 1958 Dec;37(12):1686–1692. doi: 10.1172/JCI103760. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. WOODS J. W., WELT L. G., HOLLANDER W., Jr, NEWTON M. Susceptibility of rats to experimental pyelonephritis following recovery from potassium depletion. J Clin Invest. 1960 Jan;39:28–33. doi: 10.1172/JCI104023. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES